{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:44:42Z","timestamp":1785465882930,"version":"3.56.0"},"reference-count":12,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T00:00:00Z","timestamp":1505692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Von Willebrand disease (VWD) is the most frequent inherited bleeding disorder and is caused by either a quantitative and\/or qualitative defect of the multimeric glycoprotein vonWillebrand factor (VWF).[...]<\/jats:p>","DOI":"10.3390\/jcm6090085","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T07:12:50Z","timestamp":1505805170000},"page":"85","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of Octocog Alfa (Advate) in a Child with Type 3 von Willebrand Disease and Alloantibodies"],"prefix":"10.3390","volume":"6","author":[{"given":"Gianluca","family":"Sottilotta","sequence":"first","affiliation":[{"name":"UOSD Microcitemie\u2013Emostasi e Trombosi, Grande Ospedale Metropolitano \u201cBianchi-Melacrino Morelli\u201d Reggio Calabria, Reggio Calabria 89100, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Luise","sequence":"additional","affiliation":[{"name":"UOSD Microcitemie\u2013Emostasi e Trombosi, Grande Ospedale Metropolitano \u201cBianchi-Melacrino Morelli\u201d Reggio Calabria, Reggio Calabria 89100, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Massara","sequence":"additional","affiliation":[{"name":"UOSD Microcitemie\u2013Emostasi e Trombosi, Grande Ospedale Metropolitano \u201cBianchi-Melacrino Morelli\u201d Reggio Calabria, Reggio Calabria 89100, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Oriana","sequence":"additional","affiliation":[{"name":"UOSD Microcitemie\u2013Emostasi e Trombosi, Grande Ospedale Metropolitano \u201cBianchi-Melacrino Morelli\u201d Reggio Calabria, Reggio Calabria 89100, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Piromalli","sequence":"additional","affiliation":[{"name":"UOSD Microcitemie\u2013Emostasi e Trombosi, Grande Ospedale Metropolitano \u201cBianchi-Melacrino Morelli\u201d Reggio Calabria, Reggio Calabria 89100, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,9,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2012-10-462085","article-title":"Alloantibodies in von Willebrand disease","volume":"122","author":"James","year":"2013","journal-title":"Blood"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease","volume":"71","author":"Sadler","year":"1994","journal-title":"Thromb. Haemost."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1538-7836.2007.02562.x","article-title":"Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin\u00ae): A prospective study of 50 patients","volume":"5","author":"Federici","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_4","first-page":"117","article-title":"Italian Association of Hemophilia Centers. Evidence-based recommendations on the treatment of von Willebrand disease in Italy","volume":"7","author":"Mannucci","year":"2009","journal-title":"Blood Transfus."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1182\/blood.V97.7.1915","article-title":"How I treat patients with von Willebrand disease","volume":"97","author":"Mannucci","year":"2001","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-2516.2002.00672.x","article-title":"Guidelines for the diagnosis and management of von Willebrand disease in Italy","volume":"8","author":"Federici","year":"2002","journal-title":"Haemophilia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1111\/j.1365-2516.2012.02799.x","article-title":"The challenging management of a child with Type 3 von Willebrand disease and antibodies to von Willebrand factor","volume":"18","author":"Pergantou","year":"2012","journal-title":"Haemophilia"},{"key":"ref_8","first-page":"150","article-title":"Use of recombinant factor VIIa (NovoSeven) in the treatment of two patients with Type III von Willebrand\u2019s disease and an inhibitor against von Willebrand factor","volume":"26","author":"Ciavarella","year":"1996","journal-title":"Haemostasis"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3324\/haematol.2012.077263","article-title":"Principles of care for the diagnosis and treatment of von Willebrand disease","volume":"98","author":"Castaman","year":"2013","journal-title":"Haematologica"},{"key":"ref_10","first-page":"348","article-title":"Posttransfusional anaphylactic reactions in a patient with severe von Willebrand disease: Role of complement and alloantibodies to von Willebrand Factor","volume":"125","author":"Bergamaschini","year":"1995","journal-title":"J. Lab. Clin. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1538-7836.2003.00009.x","article-title":"Multi-therapeutic approach to manage delivery in an alloimmunized patient with Type 3 von Willebrand disease","volume":"1","author":"Dreyfus","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1055\/s-0037-1613878","article-title":"Continuous infusion of recombinant factor VIIa (NovoSeven) in the treatment of a patient with Type III von Willebrand\u2019s disease and alloantibodies against von Willebrand factor","volume":"83","author":"Grossmann","year":"2000","journal-title":"Thromb. Haemost."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/6\/9\/85\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:45:11Z","timestamp":1760208311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/6\/9\/85"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,18]]},"references-count":12,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9]]}},"alternative-id":["jcm6090085"],"URL":"https:\/\/doi.org\/10.3390\/jcm6090085","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,18]]}}}